BUZZ-Tekmira Pharmaceuticals Corp: Starts making Ebola therapeutic

Wed Oct 22, 2014 8:52am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 10.1 pct at $19.80 premarket

** Company says it has started limited manufacturing of therapeutic targeting Ebola virus

** Tekmira says RNAi therapeutic, which works by preventing virus from replicating, is part of its TKM-Ebola program and will be available by early December

** Up to Tuesday's close, stock had risen 60 pct since May 27, a day after Sierra Leone first confirmed Ebola outbreak